Baucus Comments on Finance Committee Report of Glied Nomination
To: Reporters and Editors
From: Scott Mulhauser and Erin Shields
for Senate Finance Committee Chairman Max Baucus (D-Mont.)
Re: Finance Committee Report of Glied Nomination
Senate Finance Committee Chairman Max Baucus (D-Mont.) issued the following statement today on the Finance Committee’s vote to successfully report the nomination of Dr. Sherry Glied as the Department of Health and Human Services (HHS) Assistant Secretary for Planning and Evaluation. From Chairman Baucus:
“Planning and evaluation is one of the most important functions in HHS and underpins much of the Department’s activities. Dr. Glied is extremely well-suited for this position and, if confirmed, she will provide HHS with the strong foundation of evidence it needs to inform decision-making on all matters. I’m confident her wealth of experience will help Dr. Glied ensure our country has the affordable health care system it needs to thrive in the 21st century global economy. I have urged Dr. Glied to always think of the effect HHS policies will have on the American people in her new role.”
The Senate Finance Committee today reported Glied’s nomination unanimously. The nomination will now go to the full Senate for consideration.
Dr. Glied, who is a Professor and Chair in the Department of Health Policy and Management at Columbia University, was a participant in President Clinton's Health Care Task Force and served as a Senior Economist for health care and labor market policy to Clinton’s President's Council of Economic Advisers.
As the Assistant Secretary for Planning and Evaluation, Glied would be the principal advisor to HHS Secretary Kathleen Sebelius on policy development on a range of issues including health, disability, human services and science. She would also be responsible for researching the cost and benefits of related policies and programs being considered by HHS and Congress.
Next Article Previous Article
- ICYMI: Grassley Expects Prescription Drug Bill to Pass by May 20
- Azar on Grassley-Wyden: No Price Controls, No Impact on Innovation
- Grassley Speaks to Iowa Business Leaders on Lowering Prescription Drug Prices
- ICYMI: Multiemployer Pensions Take Center Stage in 2020
- Grassley at Hearing on President Trump’s Proposed 2021 Budget, Secretary Alex Azar Testimony